ProMIS Neurosciences Inc.

NASDAQ: PMN
Share price (3/20/25): $0.66
Market cap (3/20/25): $21.6 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration – amended

Ownership Filter

Armistice Capital, LLC

Great Point Partners LLC

News Filter

Doses First Patients in Phase 1b PRECISE-AD Trial of PMN310 for Alzheimer’s Disease

Change in Directors, Officers or Compensation

Investor Presentation

Initiates Phase 1b Clinical Trial (PRECISE-AD) in Alzheimer’s Disease

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission

Notice of effectiveness